Clever Leaves Holdings Inc
OTC:CLVR

Watchlist Manager
Clever Leaves Holdings Inc Logo
Clever Leaves Holdings Inc
OTC:CLVR
Watchlist
Price: 0.0002 USD
Market Cap: 43.9k USD

Relative Value

The Relative Value of one CLVR stock under the Base Case scenario is 0.0695 USD. Compared to the current market price of 0.0002 USD, Clever Leaves Holdings Inc is Undervalued by 100%.

Relative Value is the estimated value of a stock based on various valuation multiples like P/E and EV/EBIT ratios. It offers a quick snapshot of a stock's valuation in relation to its peers and historical norms.

CLVR Relative Value
Base Case
0.0695 USD
Undervaluation 100%
Relative Value
Price
Worst Case
Base Case
Best Case

Valuation Multiples

vs History
vs Industry
89
Median 3Y
0.3
Median 5Y
0.6
Industry
2.5
Forward
0
vs History
vs Industry
Median 3Y
-0.2
Median 5Y
-0.4
Industry
21.6
Forward
-0
vs History
vs Industry
Median 3Y
-0.4
Median 5Y
-0.8
Industry
16.7
vs History
vs Industry
Median 3Y
-0.3
Median 5Y
-0.5
Industry
24
vs History
vs Industry
80
Median 3Y
0.2
Median 5Y
0.3
Industry
2.2
vs History
vs Industry
Median 3Y
-0
Median 5Y
0.2
Industry
2.7
Forward
-0.2
vs History
vs Industry
Median 3Y
-0.1
Median 5Y
0.6
Industry
5.3
vs History
0
vs Industry
54
Median 3Y
0
Median 5Y
-0.4
Industry
12.9
Forward
1.2
vs History
0
vs Industry
52
Median 3Y
0
Median 5Y
-0.4
Industry
16.3
Forward
0.6
vs History
0
vs Industry
55
Median 3Y
0.1
Median 5Y
-0.3
Industry
15.2
vs History
0
vs Industry
42
Median 3Y
0.1
Median 5Y
-0.3
Industry
17.7
vs History
vs Industry
Median 3Y
-0
Median 5Y
0.1
Industry
1.9

Multiples Across Competitors

CLVR Competitors Multiples
Clever Leaves Holdings Inc Competitors

Market Cap P/S P/E EV/EBITDA EV/EBIT
CO
Clever Leaves Holdings Inc
OTC:CLVR
43.9k USD 0 -0 0.5 0.4
US
Eli Lilly and Co
NYSE:LLY
745.9B USD 15.3 67.4 36.1 39.4
UK
Dechra Pharmaceuticals PLC
LSE:DPH
440.4B GBP 578.3 -15 783.5 3 846.3 17 702.3
US
Johnson & Johnson
NYSE:JNJ
391.9B USD 4.4 18 13.1 17.2
DK
Novo Nordisk A/S
CSE:NOVO B
1.9T DKK 6.2 18.1 12.5 14.4
CH
Roche Holding AG
SIX:ROG
204B CHF 3.4 24.6 9.3 10.8
CH
Novartis AG
SIX:NOVN
182.4B CHF 4.3 17.6 10.4 14
UK
AstraZeneca PLC
LSE:AZN
160.1B GBP 3.9 27.6 130.6 196.9
US
Merck & Co Inc
NYSE:MRK
206.1B USD 3.2 11.9 8.8 10.7
IE
Endo International PLC
LSE:0Y5F
183.8B USD 79.3 -62.9 292.4 733.2
US
Pfizer Inc
NYSE:PFE
139.8B USD 2.2 17.7 7.6 10.7
P/E Multiple
Earnings Growth PEG
CO
Clever Leaves Holdings Inc
OTC:CLVR
Average P/E: 25.4
Negative Multiple: -0
N/A N/A
US
Eli Lilly and Co
NYSE:LLY
67.4
49%
1.4
UK
Dechra Pharmaceuticals PLC
LSE:DPH
Negative Multiple: -15 783.5 N/A N/A
US
Johnson & Johnson
NYSE:JNJ
18
27%
0.7
DK
Novo Nordisk A/S
CSE:NOVO B
18.1
18%
1
CH
Roche Holding AG
SIX:ROG
24.6
32%
0.8
CH
Novartis AG
SIX:NOVN
17.6
17%
1
UK
AstraZeneca PLC
LSE:AZN
27.6
36%
0.8
US
Merck & Co Inc
NYSE:MRK
11.9
17%
0.7
IE
E
Endo International PLC
LSE:0Y5F
Negative Multiple: -62.9 N/A N/A
US
Pfizer Inc
NYSE:PFE
17.7
30%
0.6
EV/EBITDA Multiple
EBITDA Growth EV/EBITDA to Growth
CO
Clever Leaves Holdings Inc
OTC:CLVR
Average EV/EBITDA: 397
0.5
N/A N/A
US
Eli Lilly and Co
NYSE:LLY
36.1
30%
1.2
UK
Dechra Pharmaceuticals PLC
LSE:DPH
3 846.3
36%
106.8
US
Johnson & Johnson
NYSE:JNJ
13.1
7%
1.9
DK
Novo Nordisk A/S
CSE:NOVO B
12.5
13%
1
CH
Roche Holding AG
SIX:ROG
9.3
5%
1.9
CH
Novartis AG
SIX:NOVN
10.4
5%
2.1
UK
AstraZeneca PLC
LSE:AZN
130.6
10%
13.1
US
Merck & Co Inc
NYSE:MRK
8.8
8%
1.1
IE
E
Endo International PLC
LSE:0Y5F
292.4
N/A N/A
US
Pfizer Inc
NYSE:PFE
7.6
2%
3.8
EV/EBIT Multiple
EBIT Growth EV/EBIT to Growth
CO
Clever Leaves Holdings Inc
OTC:CLVR
Average EV/EBIT: 1 704.5
0.4
N/A N/A
US
Eli Lilly and Co
NYSE:LLY
39.4
32%
1.2
UK
Dechra Pharmaceuticals PLC
LSE:DPH
17 702.3
98%
180.6
US
Johnson & Johnson
NYSE:JNJ
17.2
13%
1.3
DK
Novo Nordisk A/S
CSE:NOVO B
14.4
14%
1
CH
Roche Holding AG
SIX:ROG
10.8
6%
1.8
CH
Novartis AG
SIX:NOVN
14
10%
1.4
UK
AstraZeneca PLC
LSE:AZN
196.9
23%
8.6
US
Merck & Co Inc
NYSE:MRK
10.7
11%
1
IE
E
Endo International PLC
LSE:0Y5F
733.2
N/A N/A
US
Pfizer Inc
NYSE:PFE
10.7
10%
1.1